6.
Huang Z, Gao Y, Wen W, Li H, Zheng W, Shu X
. Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study. Int J Cancer. 2015; 137(3):607-14.
PMC: 4437849.
DOI: 10.1002/ijc.29412.
View
7.
Zheng W, McLerran D, Rolland B, Zhang X, Inoue M, Matsuo K
. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011; 364(8):719-29.
PMC: 4008249.
DOI: 10.1056/NEJMoa1010679.
View
8.
Husby A, Wohlfahrt J, Melbye M
. Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study. Int J Cancer. 2022; 151(10):1717-1725.
PMC: 9796914.
DOI: 10.1002/ijc.34192.
View
9.
Lukanova A, Kaaks R
. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev. 2005; 14(1):98-107.
View
10.
Wentzensen N, Poole E, Trabert B, White E, Arslan A, Patel A
. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol. 2016; 34(24):2888-98.
PMC: 5012665.
DOI: 10.1200/JCO.2016.66.8178.
View
11.
Dixon-Suen S, Nagle C, Thrift A, Pharoah P, Ewing A, Pearce C
. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018; 118(8):1123-1129.
PMC: 5931085.
DOI: 10.1038/s41416-018-0011-3.
View
12.
Larsson S, Carter P, Vithayathil M, Kar S, Mason A, Burgess S
. Insulin-like growth factor-1 and site-specific cancers: A Mendelian randomization study. Cancer Med. 2020; 9(18):6836-6842.
PMC: 7520358.
DOI: 10.1002/cam4.3345.
View
13.
Giovannucci E
. A growing link-what is the role of height in cancer risk?. Br J Cancer. 2019; 120(6):575-576.
PMC: 6461981.
DOI: 10.1038/s41416-018-0370-9.
View
14.
Tsuji I, Nishino Y, Tsubono Y, Suzuki Y, Hozawa A, Nakaya N
. Follow-up and mortality profiles in the Miyagi Cohort Study. J Epidemiol. 2004; 14 Suppl 1:S2-6.
PMC: 8828277.
DOI: 10.2188/jea.14.s2.
View
15.
Jasienska G, Bribiescas R, Furberg A, Helle S, la Mora A
. Human reproduction and health: an evolutionary perspective. Lancet. 2017; 390(10093):510-520.
DOI: 10.1016/S0140-6736(17)30573-1.
View
16.
DerSimonian R, Laird N
. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88.
DOI: 10.1016/0197-2456(86)90046-2.
View
17.
Choi Y, Lee D, Han K, Yoon H, Shin C, Park Y
. Adult height in relation to risk of cancer in a cohort of 22,809,722 Korean adults. Br J Cancer. 2019; 120(6):668-674.
PMC: 6462046.
DOI: 10.1038/s41416-018-0371-8.
View
18.
Cramer D, Welch W
. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983; 71(4):717-21.
View
19.
Yun B, Park E, Ha J, Lee J, Lee K, Lee T
. Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry. Obstet Gynecol Sci. 2023; 66(6):545-561.
PMC: 10663396.
DOI: 10.5468/ogs.23208.
View
20.
Fathalla M
. Incessant ovulation--a factor in ovarian neoplasia?. Lancet. 1971; 2(7716):163.
DOI: 10.1016/s0140-6736(71)92335-x.
View